CIPO Patents = 11

EPO Patents = 1

Forward Citations = 1

Loading Chart...

5 inventors (with patents filed for the assignee):

Joanne Holland (5 out of 15 patents)

Christopher Frampton (4 out of 12 patents)

Alex Eberlin (2 out of 19 patents)

4. Daniel Gooding (0 patent)

5. Alan Chorlton (0 patent)

5 patents: Sort by Forward Citations

1. 12084399 - Crystalline tranilast salts and their pharmaceutical use (2024-09-10),

2. 12049452 - Olaparib hydroxybenzoic acid cocrystals and their pharmaceutical use (2024-07-30),

3. 12012386 - Olaparib oxalic acid cocrystals and their pharmaceutical use (2024-06-18),

4. 11078155 - Crystalline tranilast salts and their pharmaceutical use (2021-08-03),

5. 10150729 - Tranilast compositions and cocrystals (2018-12-11),

Nuformix Technologies Limited is a pharmaceutical development company focused on bringing innovative drug treatments to market. With a unique approach to drug discovery using cocrystal technology, Nuformix is able to enhance the therapeutic properties of existing drugs. Their mission is to provide patients with improved treatment options for a range of medical conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

5 Patents

#144 in Cambridge

#3,135 in United Kingdom

Cambridge, United Kingdom

Nuformix Technologies Limited

Forward Citations = 1

5 inventors:

Joanne Holland (5 out of 15 patents)

Christopher Frampton (4 out of 12 patents)

Alex Eberlin (2 out of 19 patents)

4. Daniel Gooding (0 patent)

5. Alan Chorlton (0 patent)

Please report any incorrect information to support@idiyas.com

11 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com